Monday, November 23, 2026

Paralysis-causing 'scar' turned into nerve cells, restoring hind-leg movement [Health LAB]

Input
2026-09-18 06:00:00
Updated
2026-09-18 06:00:00
Medical staff examining a patient's spine. Newsis
[Financial News] A new technology has been developed that converts scars formed after spinal cord injuries into nerve cells, helping restore paralysis.
According to the Institute for Basic Science (IBS) on the 18th, the Cognitive and Glioscience Group of the IBS Center for Memory and Glioscience, together with Professor Ha Yoon's research team at Yonsei University College of Medicine, devised a strategy to use glial scars as a resource for nerve regeneration. The researchers developed TRANsCre-DIONE, a selective gene-expression technology.
According to the research team, spinal cord injury is a representative intractable disease in which neural regeneration and functional recovery are severely limited once the injury occurs. This is because reactive astrocytes proliferate excessively at the injury site and form a glial scar. The scar is known to serve as a defensive barrier that prevents further damage from spreading, but it also obstructs the regrowth of damaged neurons and the restoration of neural circuits.
Using TRANsCre-DIONE, the researchers made Neurogenin-2 (NGN2)—a protein that acts as a switch to induce specific cells to differentiate into neurons—express only in reactive astrocytes at the spinal cord injury site. They then transdifferentiated the reactive astrocytes into functional neurons with motor neuron characteristics. The converted cells did more than simply acquire the shape of neurons. They fully performed neuronal functions, including generating electrical signals and connecting with surrounding neural circuits to form synapses.
The researchers successfully restored neural circuits by directly converting only the reactive astrocytes at the injury site into motor neurons.
In addition, the researchers confirmed that the genetic master switch NGN2 acts like a 'chameleon.' When injected into the striatum of mice, it transformed cells into GABAergic neurons, which account for the largest proportion of cells in that region. When injected into the spinal cord, it transformed them into motor neurons responsible for motor function. In other words, the team discovered a customized differentiation mechanism that can transform selected astrocytes into the neurons most needed in a given environment.
When the technology was applied to a mouse striatal injury model, 62% of the neurons were replaced. In the striatal environment of crab-eating macaques, a complex primate model with stringent filtering requirements, the researchers demonstrated a high targeting precision of 93.13% and the potential for cell conversion, confirming the possibility of advancing the technology to human clinical trials. Furthermore, in experiments applying TRANsCre-DIONE to a mouse model of spinal cord injury, the team recorded a world-leading neural conversion efficiency of 87%. The treatment reconstructed neural circuits around the injury site and successfully restored motor function in the mice's paralyzed hind legs.
The TRANsCre-DIONE system developed by the researchers induces nerve regeneration using only astrocytes already present in the body. It was designed to leave normal cells unaffected and activate genes only in reactive astrocytes at the injury site. Therefore, unlike existing treatments such as stem cell transplantation or the administration of external cells, it eliminates at the source serious side effects such as immune reactions and tumor formation.
Changjoon Justin Lee, head of the research center and corresponding author, said, "The TRANsCre-DIONE technology will be widely used to treat various neurological diseases, including spinal cord injury, amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and stroke. Just as astrocytes magically transform into neurons, I hope TRANsCre-DIONE will be put into practical use as soon as possible, bringing about the miraculous moment when patients with spinal cord injuries can stand again."
The findings were published online on September 11 in Experimental & Molecular Medicine, a sister journal of Nature.
[email protected] Yeon Ji-an Reporter